Literature DB >> 1505583

Fatal pancytopenia during high-dose valproate monotherapy.

J Rajantie, M Kajosaari, V Ylitalo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1505583     DOI： 10.1007/bf01957735

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  8 in total

1.  Neutropenia during sodium valproate treatment.

Authors:  J Jaeken; C van Goethem; P Casaer; H Devlieger; E Eggermont; M Pilet
Journal:  Arch Dis Child       Date:  1979-12       Impact factor: 3.791

2.  Valproic acid-induced cytopenias: evidence for a dose-related suppression of hematopoiesis.

Authors:  R G Watts; P D Emanuel; K S Zuckerman; T H Howard
Journal:  J Pediatr       Date:  1990-09       Impact factor: 4.406

3.  Valproic-acid-induced pancytopenia and Coombs test positivity.

Authors:  I S Kaya; U Dilmen; M Toppare; D A Senses; H G Prentice
Journal:  Lancet       Date:  1991-05-18       Impact factor: 79.321

4.  Severe hematologic toxicity of valproic acid. A report of four patients.

Authors:  D J Ganick; T Sunder; J L Finley
Journal:  Am J Pediatr Hematol Oncol       Date:  1990

5.  Pure red cell aplasia associated with sodium valproate therapy.

Authors:  L G MacDougall
Journal:  JAMA       Date:  1982-01-01       Impact factor: 56.272

6.  Valproic acid and immune thrombocytopenia.

Authors:  R D Barr; S A Copeland; M L Stockwell; N Morris; J C Kelton
Journal:  Arch Dis Child       Date:  1982-09       Impact factor: 3.791

7.  Infantile spasms treated with high doses of sodium valproate: initial response and follow-up.

Authors:  J M Prats; C Garaizar; M J Rua; M L Garcia-Nieto; P Madoz
Journal:  Dev Med Child Neurol       Date:  1991-07       Impact factor: 5.449

Review 8.  Side effects of valproate.

Authors:  F E Dreifuss; D H Langer
Journal:  Am J Med       Date:  1988-01-25       Impact factor: 4.965
  8 in total
  4 in total

1.  Case files of the Children's Hospital of Michigan Regional Poison Control Center: the use of carnitine for the management of acute valproic acid toxicity.

Authors:  Abhishek Katiyar; Cynthia Aaron
Journal:  J Med Toxicol       Date:  2007-09

2.  A cellular model for drug interactions on hematopoiesis: the use of human umbilical cord blood progenitors as a model for the study of drug-related myelosuppression of normal hematopoiesis.

Authors:  M C Léglise; P Darodes de Tailly; J L Vignot; M A Le Bot; A M Le Roux; C Riché
Journal:  Cell Biol Toxicol       Date:  1996-02       Impact factor: 6.691

3.  Haematological disturbances during long-term valproate therapy.

Authors:  B Brichard; C Vermylen; J M Scheiff; J Ninane; G Cornu
Journal:  Eur J Pediatr       Date:  1994-05       Impact factor: 3.183

Review 4.  Valproic acid and fatalities in children: a review of individual case safety reports in VigiBase.

Authors:  Kristina Star; I Ralph Edwards; Imti Choonara
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.